Pubblicazioni

Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management

2022 - NEUROTHERAPEUTICS
Vanoli, F.; Mantegazza, R.

Glycan-Lectin Interactions as Novel Immunosuppression Drivers in Glioblastoma

2022 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Pace, Angelica; Scirocchi, Fabio; Napoletano, Chiara; Zizzari, Ilaria Grazia; D’Angelo, Luca; Santoro, Antonio; Nuti, Marianna; Rahimi, Hassan; Rughetti, Aurelia

Detection analysis and study of genomic region variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the urine and plasma of HIV-1-infected patients

2022 - VIRUSES
Passerini, Sara; Prezioso, Carla; Prota, Annalisa; Babini, Giulia; Coppola, Luigi; Lodi, Alessandra; Chiara Epifani, Anna; Sarmati, Loredana; Andreoni, Massimo; Moens, Ugo; Pietropaolo, Valeria Antonietta; Ciotti, Marco

Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin

2022 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Pagano, MARIA TERESA; Fecchi, Katia; Pierdominici, Marina; Ortona, Elena; Peruzzu, Daniela

What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis?

2022 - EXPERT OPINION ON PHARMACOTHERAPY
Vanoli, F; Mantegazza, R

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma